{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:48:51Z","timestamp":1762145331693},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Higher Education of Shandong Province"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31270391"],"award-info":[{"award-number":["31270391"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ejphar.2018.03.041","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T18:32:09Z","timestamp":1522348329000},"page":"97-102","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Long-term oral atazanavir attenuates myocardial infarction-induced cardiac fibrosis"],"prefix":"10.1016","volume":"828","author":[{"given":"Guanghua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Defang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanglin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.03.041_bib1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbamcr.2012.08.023","article-title":"Fibroblasts in post-infarction inflammation and cardiac repair","volume":"1833","author":"Chen","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2018.03.041_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/01.RES.73.1.184","article-title":"Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding","volume":"73","author":"Feldman","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2018.03.041_bib3","first-page":"57","article-title":"Experimental myocardial infarction in the rat, qualitative and quantitative changes during pathologic evolution","volume":"90","author":"Fishbein","year":"1978","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2018.03.041_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbrc.2008.08.096","article-title":"Role of TLR9 in hepatic stellate cells and experimental liver fibrosis","volume":"376","author":"G\u00e4bele","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2018.03.041_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/cvr\/cvq274","article-title":"Cardiomyocyte NF-\u03baB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure","volume":"89","author":"Hamid","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2018.03.041_bib6","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1182\/blood-2006-09-044776","article-title":"A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA","volume":"110","author":"Ivanov","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2018.03.041_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.phymed.2009.10.017","article-title":"Cardioprotection with for sythoside B in rat myocardial ischemia-reperfusion injury: relation to inflammation response","volume":"17","author":"Jiang","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2018.03.041_bib8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijcard.2011.06.010","article-title":"Cardioprotection of Asperosaponin X on experimental myocardial ischemia injury","volume":"155","author":"Jiang","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2018.03.041_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yjmcc.2015.12.009","article-title":"Thrombospondins in the transition from myocardial infarction to heart failure","volume":"90","author":"Kirk","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2018.03.041_bib10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0002-9149(99)80686-9","article-title":"Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis","volume":"75","author":"Klappacher","year":"1995","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2018.03.041_bib11","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2165\/00003088-200544100-00003","article-title":"Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir","volume":"44","author":"Le Tiec","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2018.03.041_bib12","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1111\/jcmm.12419","article-title":"Emerging role of HMGB1 in fibrotic diseases","volume":"18","author":"Li","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ejphar.2018.03.041_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/hc0602.103674","article-title":"Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction","volume":"105","author":"Lindsey","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2018.03.041_bib14","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1021\/acs.jafc.6b03001","article-title":"Protective effect of RA on myocardial infarction-induced cardiac fibrosis via AT1R\/p38 MAPK pathway signaling and modulation of the ACE2\/ACE ratio","volume":"64","author":"Liu","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2018.03.041_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1protein (HMGB1), nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2018.03.041_bib16","doi-asserted-by":"crossref","first-page":"9692","DOI":"10.1021\/jf802050h","article-title":"Akt\/FOXO3a\/ SIRT1-mediated cardioprotection by ntyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevity","volume":"56","author":"Samuel","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2018.03.041_bib17","doi-asserted-by":"crossref","first-page":"C53","DOI":"10.1152\/ajpcell.2001.280.1.C53","article-title":"Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts","volume":"280","author":"Siwik","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2018.03.041_bib18","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/jcmm.12324","article-title":"Up-regulated HMGB1 in EAM directly led to collagen deposition by a PKC\u03b2\/Erk1\/2-dependent pathway: cardiac fibroblast\/myofibroblast might be another source of HMGB1","volume":"18","author":"Su","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ejphar.2018.03.041_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00395-002-0365-8","article-title":"Infarct scar as living tissue","volume":"97","author":"Sun","year":"2002","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejphar.2018.03.041_bib20","doi-asserted-by":"crossref","first-page":"11683","DOI":"10.1021\/jf802357g","article-title":"Preventive effects of nutritional doses of polyphenolic molecules on cardiac fibrosis associated with metabolic syndrome: involvement of osteopontin and oxidative stress","volume":"56","author":"Sutra","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2018.03.041_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ni1457","article-title":"Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE","volume":"8","author":"Tian","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2018.03.041_bib22","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1161\/01.CIR.88.6.2849","article-title":"Identification of functional angiotensin II receptors on rat cardiac fibroblasts","volume":"88","author":"Villarreal","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2018.03.041_bib23","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hep.21867","article-title":"Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9","volume":"46","author":"Watanabe","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2018.03.041_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.1104648","article-title":"The cytokine activity of HMGB1","volume":"78","author":"Yang","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2018.03.041_bib25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/cvr\/cvp237","article-title":"NF-kappaB activation is required for adaptive cardiac hypertrophy","volume":"84","author":"Zelarayan","year":"2009","journal-title":"Cardiovasc. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918302012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918302012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T18:22:58Z","timestamp":1534962178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918302012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":25,"alternative-id":["S0014299918302012"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.03.041","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term oral atazanavir attenuates myocardial infarction-induced cardiac fibrosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.03.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}